Need help? Call us on +44 (0)20 7613 3444 or email
How to Gain Approval to Conduct Clinical Trials in Europe (CT01)
To conduct a clinical trial in the European Economic Area the sponsor must apply for authorisation from the national competent authority (i.e. medicines regulator), and favourable opinion must be obtained from a research ethics committee, in each member state in which the trial is to take place. This module sets out the requirements for successful compilation, submission and maintenance of the applications.
In addition to being fully compliant with current European Union legislation, the module looks forward to the implementation of the Clinical Trials Regulation.
Who will benefit from this module?
The module will benefit:
- regulatory affairs professionals and other staff of pharmaceutical or biotechnology companies involved in clinical development of medicinal products; and
- healthcare professionals conducting clinical research as sponsor-investigators.
It will be of particular value to those who are new to European regulatory affairs, but familiarity with the basics of Good Clinical Practice is assumed.
- Outline the legal and regulatory framework that governs clinical trials in the European Economic Area
- Summarise the procedures that must be carried out to gain approval to proceed with a trial
- Identify the principal components of an application to a national competent authority for clinical trial authorisation and describe their contents
- Discuss the principal areas of concern to an ethics committee and describe the information to be submitted to one
- Specify what measures must be taken to maintain the authorisation of a trial in progress
- Identify changes that will be brought about by the Clinical Trials Regulation
Overview - An outline of the module’s scope and objectives, and notes on terminology.
The European context - This session explains the legal and regulatory framework for clinical trials in Europe.
Applying for approval - This session outlines the application procedures for clinical trial authorisation (CTA) and for ethics committee (EC) favourable opinion. It provides a decision tree through which you can determine whether your prospective investigation is a clinical trial. It describes how to register a trial with the EudraCT database and obtain a EudraCT number. It summarises the contents of applications and the processes and outcomes of reviews.
Application for clinical trial authorisation - The contents of a CTA application are discussed in more detail, focusing on the investigator’s brochure, investigational medicinal product (IMP) dossier, circumstances in which a simplified IMPD or Summary of Product Characteristics may be substituted, and other IMP-related data. Online compilation of the application form is explained.
Application for ethics committee favourable opinion - Significant features of an application for EC favourable opinion are discussed in more detail, including the clinical protocol, informed consent form, and subject recruitment materials.
Maintaining authorisation - This session deals with the regulatory compliance activities that have to be carried out once a clinical trial has been approved. It examines the procedure for submitting substantial amendments, safety reporting requirements, and declaration of the end of a trial.
The Clinical Trials Regulation - This short session looks forward to the introduction of the Clinical Trials Regulation, which will replace the Clinical Trials Directive and establish greater uniformity in procedures for approval of clinical trials throughout the EEA.
Assessment - Multiple-choice mastery assessment.